8SJ logo

Shanghai Junshi Biosciences DB:8SJ Stock Report

Last Price

€1.45

Market Cap

€3.3b

7D

-5.8%

1Y

n/a

Updated

22 Dec, 2024

Data

Company Financials +

Shanghai Junshi Biosciences Co., Ltd.

DB:8SJ Stock Report

Market Cap: €3.3b

8SJ Stock Overview

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. More details

8SJ fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Revenue is forecast to grow 29.55% per year

Trading at good value compared to peers and industry

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Currently unprofitable and not forecast to become profitable over the next 3 years


My Notes

Capture your thoughts, links and company narrative

Shanghai Junshi Biosciences Co., Ltd. Competitors

Biotest

XTRA:BIO3

€1.3b

Formycon

XTRA:FYB

€905.8m

Heidelberg Pharma

XTRA:HPHA

€105.8m

SCHOTT Pharma KGaA

XTRA:1SXP

€3.7b

Price History & Performance

Summary of share price highs, lows and changes for Shanghai Junshi Biosciences
Historical stock prices
Current Share PriceHK$1.45
52 Week HighHK$2.42
52 Week LowHK$1.06
Beta0.41
1 Month Change0%
3 Month Change23.93%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-72.87%

Recent News & Updates

Recent updates

Shareholder Returns

8SJDE BiotechsDE Market
7D-5.8%-2.9%-2.6%
1Yn/a-14.7%6.9%

Return vs Industry: Insufficient data to determine how 8SJ performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how 8SJ performed against the German Market.

Price Volatility

Is 8SJ's price volatile compared to industry and market?
8SJ volatility
8SJ Average Weekly Movement12.7%
Biotechs Industry Average Movement6.8%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8SJ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 8SJ's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20122,532Cong Liwww.junshipharma.com

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

Shanghai Junshi Biosciences Co., Ltd. Fundamentals Summary

How do Shanghai Junshi Biosciences's earnings and revenue compare to its market cap?
8SJ fundamental statistics
Market cap€3.28b
Earnings (TTM)-€236.89m
Revenue (TTM)€234.77m

6.3x

P/S Ratio

-6.3x

P/E Ratio

Is 8SJ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8SJ income statement (TTM)
RevenueCN¥1.79b
Cost of RevenueCN¥622.89m
Gross ProfitCN¥1.16b
Other ExpensesCN¥2.97b
Earnings-CN¥1.80b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.83
Gross Margin65.15%
Net Profit Margin-100.90%
Debt/Equity Ratio43.8%

How did 8SJ perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 07:24
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Junshi Biosciences Co., Ltd. is covered by 19 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Congmin YuanCitic Securities Co., Ltd.
Tan Huan GanCitic Securities Co., Ltd.
Muk Tsz YungCitigroup Inc